Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise
April 16, 2023 at 17:21 PM EDT
A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%.
